SCHEMBL6709339

SCHEMBL6709339

O=C(Cn1ccc2ccccc21)c1ccc(Cl)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.61
SMN1; SMN2 Q16637 1/20 0.61
KMT2A Q03164 3/20 0.59
RAB9A P51151 2/20 0.55
NPC1 O15118 1/20 0.55
MGAM O43451 1/20 0.55
AMY1A P0DUB6 1/20 0.55
GAA P10253 1/20 0.55
SI P14410 1/20 0.55
MGAM2 Q2M2H8 1/20 0.55
HDAC1 Q13547 1/20 0.51
HDAC2 Q92769 1/20 0.51
HDAC10 Q969S8 1/20 0.51
HDAC8 Q9BY41 1/20 0.51
HDAC6 Q9UBN7 1/20 0.51
HDAC9 Q9UKV0 1/20 0.51
CXCR3 P49682 5/20 0.50
IDO1 P14902 1/20 0.50
STAT1 P42224 1/20 0.48
LMNA P02545 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6706845 0.85 KMT2A (0.59) MAPTSMN1; SMN2KMT2ARAB9AMGAM
SCHEMBL16286740 0.77 KMT2A (0.71) MAPTSMN1; SMN2KMT2AHDAC1HDAC2
SCHEMBL20454608 0.77 CA1 (0.66)
SCHEMBL29420405 0.75 KMT2A (1.00) KMT2AHDAC1HDAC2HDAC10HDAC8
SCHEMBL1598786 0.75 KMT2A (1.00) KMT2AHDAC1HDAC2HDAC10HDAC8
SCHEMBL9685245 0.75 MAPT (0.58) MAPTSMN1; SMN2KMT2ARAB9ANPC1
Hydrochloric Acid SCHEMBL25303352 0.74 KMT2A (0.96) KMT2AHDAC1HDAC2HDAC10HDAC8
SCHEMBL29459650 0.74 HTR6 (0.72) MAPTSMN1; SMN2KMT2AHDAC1HDAC2
SCHEMBL1519806 0.74 KMT2A (0.71) KMT2AHDAC1HDAC2HDAC10HDAC8
SCHEMBL9701534 0.74 KMT2A (0.71) KMT2AHDAC1HDAC2HDAC10HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040067998-A1 Antifungal and/or antiparasitic pharmaceutical composition and novel indole derivatives as active principle of such a composition YANG JI CHEMICAL COMPANY LTD (KR) 2004-04-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040067998-A1 Antifungal and/or antiparasitic pharmaceutical composition and novel indole derivatives as active principle of such a composition IDO1, IDO2, TPH1 MAPT 1200/4885SMN1; SMN2 4643/4885KMT2A 3567/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.